A novel risk-adjusted nomogram for rectal cancer surgery outcomes

JAMA Surgery

Volumn 148, Issue 8, 2013, Pages 769-777

  Russell, Maria C ^a   You, Y Nancy ^b   Hu, Chung Yuan ^b   Cormier, Janice N ^b   Feig, Barry W ^b   Skibber, John M ^b   Rodriguez Bigas, Miguel A ^b   Nelson, Heidi ^c   Chang, George J ^b  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; COLON ADENOCARCINOMA; COMMUNITY HOSPITAL; ETHNICITY; FEMALE; HEALTH CARE QUALITY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RECTUM CARCINOMA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; UNIVERSITY HOSPITAL; ADENOCARCINOMA; ADOLESCENT; HOSPITALIZATION; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MORTALITY; PATHOLOGY; RECTAL NEOPLASMS; SOCIOECONOMICS; STATISTICAL MODEL; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; NOMOGRAMS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84882996912     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.2136     Document Type: Article

References (33)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.
2. McCall JL, CoxMR,Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis. 1995;10(3):126-132.
3. Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012;30(15):1770-1776.
4. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B; Stockholm Colorectal Cancer Study Group; Basingstoke Bowel Cancer Research Project. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet. 2000;356(9224): 93-96. (Pubitemid 30438509)
5. Adam IJ, Mohamdee MO, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344(8924):707-711. (Pubitemid 24281421)
6. Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following totalmesorectal excision for rectal cancer. Br J Surg. 2002;89(3):327-334. (Pubitemid 34227032)
7. Quirke P, Steele R, Monson J, et al; MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373(9666): 821-828.
8. Marijnen CA, Nagtegaal ID, Kapiteijn E, et al; Cooperative investigators of the Dutch Colerectal Cancer Group. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys. 2003;55(5):1311-1320. (Pubitemid 36338299)
9. Baik SH, Kim NK, Lee YC, et al. Prognostic significance of circumferential resection margin following totalmesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer. Ann Surg Oncol. 2007;14(2):462-469. (Pubitemid 46175290)
10. den DulkM, Collette L, van de Velde CJ, et al EORTC Radiation Oncology Group. Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment: results from EORTC trial 22921. Eur J Cancer. 2007;43(12):1821-1828. (Pubitemid 47241247)
11. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ. 1991;302(6791):1501-1505.
12. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Local recurrence following 'curative' surgery for large bowel cancer: II, the rectum and rectosigmoid. Br J Surg. 1984;71(1):17-20. (Pubitemid 14214646)
13. Phang PT, Kennecke H,McGahan CE, Macfarlane J, McGregor G, Hay JH. Predictors of positive radial margin status in a population-based cohort of patients with rectal cancer. Curr Oncol. 2008;15(2):98-103.
14. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P; Dutch Colorectal Cancer Group; Pathology Review Committee. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23(36):9257-9264.
15. Winchester DP, Stewart AK, Bura C, Jones RS. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol. 2004;85(1):1-3. (Pubitemid 38036733)
16. Rosner B. Fundamentals of Biostatistics. 6th ed. Boston, MA: Duxbury Press; 2005.
17. Hosmer D. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley and Sons; 2000.
18. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479-1482. (Pubitemid 16095660)
19. Wibe A, Eriksen MT, Syse A, Myrvold HE, Søreide O; Norwegian Rectal Cancer Group. Total mesorectal excision for rectal cancer - what can be achieved by a national audit? Colorectal Dis. 2003;5(5):471-477. (Pubitemid 37080656)
20. Tilney HS, Tekkis PP, Sains PS, Constantinides VA, Heriot AG; Association of Coloproctology of Great Britain and Ireland. Factors affecting circumferential resection margin involvement after rectal cancer excision. Dis Colon Rectum. 2007;50(1):29-36.
21. Reshef A, Lavery I, Kiran RP. Factors associated with oncologic outcomes after abdominoperineal resection compared with restorative resection for low rectal cancer: patient- and tumor-related or technical factors only? Dis Colon Rectum. 2012;55(1):51-58.
22. Marr R, Birbeck K, Garvican J, et al. The modern abdominoperineal excision: the next challenge after totalmesorectal excision. Ann Surg. 2005;242(1):74-82. (Pubitemid 40917970)
23. Killeen SD, O'Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg. 2005;92(4):389-402. (Pubitemid 40523899)
24. Konety BR, Dhawan V, Allareddy V, Joslyn SA. Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project. J Urol. 2005;173(5):1695-1700. (Pubitemid 40524808)
25. Ellison LM, Trock BJ, Poe NR, Partin AW. The effect of hospital volume on cancer control after radical prostatectomy. J Urol. 2005;173(6):2094-2098. (Pubitemid 40675253)
26. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH; Pathology Review Committee; Cooperative Clinical Investigators. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but twomillimeters is the limit. Am J Surg Pathol. 2002;26(3):350-357. (Pubitemid 34184459)
27. Quirke P, Durdey P, Dixon MF,Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2(8514):996-999. (Pubitemid 16005611)
28. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235(4):449-457. (Pubitemid 34258342)
29. van GijnW, Marijnen CA, Nagtegaal ID, et al Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with totalmesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575-582.
30. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with totalmesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638-646.
31. Sauer R, Becker H, HohenbergerW, et al German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731-1740.
32. Roh MS, Colangelo LH, O'ConnellMJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009;27(31):5124-5130.
33. Silberfein EJ, Kattepogu KM, Hu CY, et al. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol. 2010;17(11):2863-2869.